You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 22, 2024

Details for Patent: 8,680,124


✉ Email this page to a colleague

« Back to Dashboard


Which drugs does patent 8,680,124 protect, and when does it expire?

Patent 8,680,124 protects STIVARGA and is included in one NDA.

This patent has six patent family members in five countries.

Summary for Patent: 8,680,124
Title:Treatment of cancers with acquired resistance to kit inhibitors
Abstract: The present invention provides compositions and uses thereof for treating cancers which have acquired resistance to a KIT inhibitor by administering effective amounts of DAST (4{4-[3-(4-chloro-3-trifluoromethylphenyl)-ureido]-3-fluorophenoxy}-pyrid- ine-2-carboxylic acid methylamide).
Inventor(s): Wilhelm; Scott (Morristown, NJ), Gedrich; Richard W. (Louisville, CO)
Assignee: Bayer Healthcare LLC (Whippany, NJ)
Application Number:12/523,652
Patent Litigation and PTAB cases: See patent lawsuits and PTAB cases for patent 8,680,124
Patent Claim Types:
see list of patent claims
Use;
Patent landscape, scope, and claims:

Analyzing the Scope and Claims of United States Patent 8,680,124: A Comprehensive Guide

Introduction

Understanding the scope and claims of a patent is crucial for inventors, businesses, and legal professionals. This article will delve into the specifics of United States Patent 8,680,124, exploring its claims, the patent landscape, and the tools and methods used for such analyses.

What is United States Patent 8,680,124?

To begin, it is essential to identify the patent in question. United States Patent 8,680,124 is a utility patent that was granted on April 1, 2014. The patent title, inventors, and assignees provide the first layer of information necessary for analysis.

Patent Claims

Understanding Patent Claims

Patent claims define the scope of protection granted by the patent. They are the most critical part of the patent document, as they delineate what is considered novel and non-obvious[4].

Claim Types

  • Independent Claims: These claims stand alone and define the invention without reference to other claims.
  • Dependent Claims: These claims refer back to and further limit an independent claim.

Analyzing Claims of US Patent 8,680,124

For a detailed analysis, one would need to review the specific claims listed in the patent document. Here, you would identify the independent and dependent claims, and understand how they interrelate to define the patented invention.

Patent Landscape Analysis

What is Patent Landscape Analysis?

Patent landscape analysis is a comprehensive approach to understanding the patent environment within a specific technology area. It helps in identifying key players, trends, and potential gaps in the market[3].

Tools for Patent Landscape Analysis

  • USPTO Patent Public Search: This tool provides enhanced access to prior art and is essential for conducting thorough patent searches[1].
  • Global Dossier: This service allows users to view the patent family for a specific application, including related applications from participating IP Offices[1].
  • Common Citation Document (CCD): This application consolidates citation data from multiple IP offices, providing a single point of access for prior art citations[1].

Conducting a Patent Landscape Analysis for US Patent 8,680,124

To analyze the landscape around US Patent 8,680,124, you would use the above tools to:

  • Identify key competitors and their patent portfolios.
  • Determine the level of patent saturation in the technology area.
  • Visualize the evolution of technology over time using time-slicing techniques[3].

Searching for Prior Art

Importance of Prior Art

Prior art is any evidence that your invention is already known. Conducting a thorough prior art search is crucial to ensure the novelty and non-obviousness of your invention[1].

Resources for Prior Art Search

  • USPTO Public Search Facility: Provides access to patent and trademark information in various formats[1].
  • Patent and Trademark Resource Centers (PTRCs): Offers local search resources and training in patent search techniques[1].
  • Patent Official Gazette: Allows users to browse issued patents for the current week, categorized by classification or type of patent[1].

Patent Assignment and Ownership

Understanding Patent Assignments

Patent assignments refer to the transfer of ownership of a patent. This information is critical for understanding the current and past ownership of a patent[1].

Searching for Patent Assignments

The USPTO provides a Patent Assignment Search tool to search for patent assignments and changes in ownership. This tool helps in tracing the ownership history of a patent[1].

Patent Examination Data

Accessing Examination Data

The Patent Examination Data System (PEDS) allows users to search, view, and download bibliographic data for publicly available patent applications. This data can provide insights into the examination process and the likelihood of patent allowance[1].

Analyzing Allowance Rates

Studies on patent allowance rates, such as those conducted using USPTO internal databases, can help in understanding the probability of receiving a patent. This includes first-action allowance rates, progenitor allowance rates, and family allowance rates[4].

Strategic Insights from Patent Landscape Analysis

Identifying Market Trends

A comprehensive patent landscape analysis can help in identifying market trends and areas of high patent saturation. This information is vital for business and R&D management to make long-term decisions about technology investments[3].

Example: Time-Slicing Analysis

Time-slicing analysis can reveal how a company's patent portfolio has evolved over time. For instance, if a company has significantly reduced patent filings in a particular technology area, it may indicate a shift in their strategic focus[3].

Key Takeaways

  • Detailed Claims Analysis: Understanding the claims of a patent is essential for defining the scope of protection.
  • Patent Landscape Tools: Utilize tools like USPTO Patent Public Search, Global Dossier, and CCD for comprehensive landscape analysis.
  • Prior Art Search: Conduct thorough prior art searches using resources like the USPTO Public Search Facility and PTRCs.
  • Patent Assignments: Use the Patent Assignment Search tool to track ownership changes.
  • Examination Data: Analyze bibliographic data from PEDS to understand the examination process and allowance rates.

FAQs

Q: What is the purpose of a patent landscape analysis?

A: Patent landscape analysis helps in understanding the patent environment within a specific technology area, identifying key players, trends, and potential gaps in the market.

Q: How do I search for prior art related to a patent?

A: You can use resources like the USPTO Public Search Facility, PTRCs, and the Patent Official Gazette to conduct a thorough prior art search.

Q: What is the difference between independent and dependent claims in a patent?

A: Independent claims stand alone and define the invention, while dependent claims refer back to and further limit an independent claim.

Q: How can I track the ownership history of a patent?

A: Use the USPTO’s Patent Assignment Search tool to search for patent assignments and changes in ownership.

Q: What is the significance of patent allowance rates in patent analysis?

A: Patent allowance rates help in understanding the probability of receiving a patent and can be categorized into first-action allowance rates, progenitor allowance rates, and family allowance rates.

Sources

  1. USPTO: Search for patents - USPTO.
  2. USA.gov: U.S. Patent and Trademark Office (USPTO) | USAGov.
  3. AcclaimIP: Patent Landscape Analysis - Uncovering Strategic Insights.
  4. YJOLT: What Is the Probability of Receiving a US Patent?
  5. ACUS: U.S. Patent Small Claims Court.

More… ↓

⤷  Subscribe


Drugs Protected by US Patent 8,680,124

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Submissiondate
Bayer Hlthcare STIVARGA regorafenib TABLET;ORAL 203085-001 Sep 27, 2012 RX Yes Yes ⤷  Subscribe ⤷  Subscribe TREATMENT OF PATIENTS WITH GASTROINTESTINAL STROMAL TUMOR (GIST), INCLUDING BUT NOT LIMITED TO PATIENTS PREVIOUSLY TREATED WITH IMATINIB AND PATIENTS WITH GIST HAVING RESISTANCE TO A KIT TYROSINE KINASE INHIBITOR ⤷  Subscribe
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Patented / Exclusive Use >Submissiondate

Foreign Priority and PCT Information for Patent: 8,680,124

PCT Information
PCT FiledJanuary 18, 2008PCT Application Number:PCT/US2008/051406
PCT Publication Date:July 24, 2008PCT Publication Number: WO2008/089389

International Family Members for US Patent 8,680,124

Country Patent Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
Canada 2675980 ⤷  Subscribe
European Patent Office 2129376 ⤷  Subscribe
Spain 2429107 ⤷  Subscribe
Japan 2010516693 ⤷  Subscribe
Japan 5885012 ⤷  Subscribe
World Intellectual Property Organization (WIPO) 2008089389 ⤷  Subscribe
>Country >Patent Number >Estimated Expiration >Supplementary Protection Certificate >SPC Country >SPC Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.